ELVN filings
Corporate insider profile
Lori Anne Kunkel Filing Activity
Latest reported as Director of Enliven Therapeutics, Inc. (ELVN).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$345,351.00
- Latest transaction
- Jun 5, 2026
Affiliated corporations
Reported company relationships
Transaction history
